Nawaloka Hospitals PLC (COSE:NHL.N0000)
Sri Lanka flag Sri Lanka · Delayed Price · Currency is LKR
0.00
0.00 (0.00%)
Price not available due to exchange restrictions

Nawaloka Hospitals Income Statement

Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
12,62111,01310,3799,30515,30211,828
Revenue Growth (YoY)
17.33%6.10%11.54%-39.19%29.38%30.90%
Cost of Revenue
5,6875,1344,7634,6707,4616,285
Gross Profit
6,9345,8785,6174,6357,8415,542
Selling, General & Admin
5,4104,9104,6183,8604,8563,753
Other Operating Expenses
-133.57-143.57-37.47258.91232.59-37.37
Operating Expenses
5,3854,8754,5924,7095,9274,042
Operating Income
1,5491,0031,025-73.461,9141,501
Interest Expense
-1,048-927.89-1,491-1,951-1,035-1,162
Interest & Investment Income
35.3128.9537.5658.5853.4648.27
Earnings From Equity Investments
223.04223.04148.53159.89--
Currency Exchange Gain (Loss)
4.34.333.73-102.56-215-24.4
Other Non Operating Income (Expenses)
-00--2.08-7.64-18.03
EBT Excluding Unusual Items
764.24331.79-247.01-1,911709.67344.61
Gain (Loss) on Sale of Investments
0.410.41----
Gain (Loss) on Sale of Assets
1.141.14---253.662.57
Asset Writedown
3.33.3----
Pretax Income
1,430336.64-247.01-1,911456.02347.17
Income Tax Expense
410.89280.2657.74527.67552.61-154.09
Net Income
1,01956.38-304.75-2,438-96.59501.26
Net Income to Common
1,01956.38-304.75-2,438-96.59501.26
Net Income Growth
-----3036.68%
Shares Outstanding (Basic)
1,4351,4101,4101,4101,4101,410
Shares Outstanding (Diluted)
1,4351,4101,4101,4101,4101,410
EPS (Basic)
0.710.04-0.22-1.73-0.070.36
EPS (Diluted)
0.710.04-0.22-1.73-0.070.36
EPS Growth
-----3456.31%
Free Cash Flow
-459.03792.792,0472,7521,259-65.36
Free Cash Flow Per Share
-0.320.561.451.950.89-0.05
Gross Margin
54.94%53.38%54.12%49.81%51.24%46.86%
Operating Margin
12.27%9.11%9.87%-0.79%12.51%12.69%
Profit Margin
8.07%0.51%-2.94%-26.21%-0.63%4.24%
Free Cash Flow Margin
-3.64%7.20%19.73%29.58%8.23%-0.55%
EBITDA
2,4231,8061,851754.972,7442,329
EBITDA Margin
19.20%16.40%17.83%8.11%17.93%19.69%
D&A For EBITDA
873.99802.41825.97828.43830.28828.33
EBIT
1,5491,0031,025-73.461,9141,501
EBIT Margin
12.27%9.11%9.87%-0.79%12.51%12.69%
Effective Tax Rate
28.74%83.25%--121.18%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.